======= ETFA ======= == Gene Information == * **Official Symbol**: ETFA * **Official Name**: electron transfer flavoprotein subunit alpha * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2108|2108]] * **UniProt**: [[https://www.uniprot.org/uniprot/P13804|P13804]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ETFA&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ETFA|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608053|Open OMIM]] == Function Summary == * **Entrez Summary**: ETFA participates in catalyzing the initial step of the mitochondrial fatty acid beta-oxidation. It shuttles electrons between primary flavoprotein dehydrogenases and the membrane-bound electron transfer flavoprotein ubiquinone oxidoreductase. Defects in electron-transfer-flavoprotein have been implicated in type II glutaricaciduria in which multiple acyl-CoA dehydrogenase deficiencies result in large excretion of glutaric, lactic, ethylmalonic, butyric, isobutyric, 2-methyl-butyric, and isovaleric acids. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Heterodimeric electron transfer flavoprotein that accepts electrons from several mitochondrial dehydrogenases, including acyl-CoA dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase (PubMed:27499296, PubMed:15159392, PubMed:15975918, PubMed:9334218, PubMed:10356313). It transfers the electrons to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) (PubMed:9334218). Required for normal mitochondrial fatty acid oxidation and normal amino acid metabolism (PubMed:12815589, PubMed:1882842, PubMed:1430199). {ECO:0000269|PubMed:10356313, ECO:0000269|PubMed:12815589, ECO:0000269|PubMed:1430199, ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918, ECO:0000269|PubMed:27499296, ECO:0000269|PubMed:9334218, ECO:0000303|PubMed:17941859, ECO:0000305|PubMed:1882842}. |ETF alpha| |ETF| |fatty acid beta-oxidation using acyl-CoA dehydrogenase| |flavin adenine dinucleotide binding| |fatty acid beta-oxidation| |electron transfer activity| |fatty acid oxidation| |lipid oxidation| |fatty acid catabolic process| |respiratory electron transport chain| |monocarboxylic acid catabolic process| |oxidoreductase activity| |cellular respiration| |electron transport chain| |cellular lipid catabolic process| |lipid modification| |energy derivation by oxidation of organic compounds| |organic acid catabolic process| |carboxylic acid catabolic process| |lipid catabolic process| |fatty acid metabolic process| |mitochondrial matrix| |generation of precursor metabolites and energy| |small molecule catabolic process| |monocarboxylic acid metabolic process| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |lipid metabolic process| |mitochondrion| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp462|Cadmium 60μM R08 exp462]]|1.79| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|1.81| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|1.82| |[[:results:exp210|LB-100 2μM R05 exp210]]|1.91| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|1.92| |[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|1.94| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.98| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|2.01| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|2.01| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.05| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|2.42| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|2.94| ^Gene^Correlation^ |[[:human genes:i:ivd|IVD]]|0.485| |[[:human genes:e:etfb|ETFB]]|0.42| |[[:human genes:h:hgc6.3|HGC6.3]]|0.405| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17484 * **Expression level (log2 read counts)**: 7.33 {{:chemogenomics:nalm6 dist.png?nolink |}}